FDA accepts Intellia's lonvo-z application with priority review status

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. QCOM
5. IONS
6. ORCL
7. AAPL
8. NVS
9. AZN
10. HOOD

Go back to FDA accepts Intellia's lonvo-z application with priority review status
(NASDAQ: NTLA) Delayed: 12.74 --0 (-0%)
Previous Close $12.74    52 Week High $30.40 
Open $12.74    52 Week Low $11.86 
Day High $12.74    P/E N/A 
Day Low $12.74    EPS $0.00 
Volume 5,859